JPRN-UMIN000038037已完成未知
The attenuating effect of HBF2019-03 on postprandial serum triglyceride level in healthy human subjects -A placebo controlled, randomized, double blind, cross-over study- - The attenuating effect of HBF2019-03 on postprandial serum triglyceride level.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •[1] Who use medical products affecting lipid metabolism. [2] Who can't stop using supplements which affecting lipid metabolism during the study period. [3] Who can't abstinent from alcohol from two days before each examination. [4] Who are allergic to placebo food and/or test food and/or the ingredient of high-fat meal. [5] Who have a history of serious kidney damage, hepatopathy, heart disease, respiratory disease, endocrine disease, or any other metabolic disease(s) or who is under medical treatment. [6] Who have chronic disease and is under medication. [7] Who have digestive organ disease or surgical history affecting digestion and absorption of foods. [8] Who are judged inappropriate for the study by the investigator in the screening. [9] Who are diagnosed as severe anemia in screening and not suitable for frequent collection of blood. [10] Who had an onset diarrhea within a week from the date of screening, and/or who are prone to diarrhea on a daily basis. [11] Who with significantly different fasting serum triglycerides levels of each test day. [12] Who have little change in serum triglyceride level after intake high-fat meal, or who continue to rise 6 hours after the meal, or who are judged abnormal changes in serum triglyceride level by the investigator in the screening. [13] Who donated blood over 200mL in the past a month or over 400mL in the past 3 months from the date of informed consent. [14] Who are diagnosed as familial hyperlipidemia. [15] Who are drug addict and/or alcohol addict. [16] Who with irregular life rhythms such as shift workers or works late at night. [17] Who are participating in other studies that using food(s), pharmaceutical(s), and cosmetic(s) now, or who have participated or are willing to participate in other studies within a month from the date of informed consent. [18] Who are or are possibly pregnant, or who are lactating, during the study period. [19] Who are judged inappropriate for the study by the investigator.
研究者
相似试验
已完成
不适用
The attenuating effect of HBF2020-02 on postprandial blood glucose levels in healthy human subjects -A placebo controlled, randomized, double blind, cross-over studyJPRN-UMIN000042161KSO Corporation50
已完成
不适用
Evaluation of the effect of HBF2020-05 intake on visual function.Healthy Japanease adultsJPRN-UMIN000045803Hayashibara CO., LTD.32
已完成
不适用
Comparative study of inhibitory effects on postprandial blood glucose levels of patients with type 2 diabetes by wax bran layer removal brown riceType 2 Diabetes MellitusJPRN-UMIN000043398Wakayama Medical university Division of Clinical Nutrition and Metabolism10
已完成
不适用
Increased inhibitory effect confirmation of postprandial glucose level by powder was wheat fermented with Bacillus.impaired glucose toleranceJPRN-UMIN000011343Mie University, Graduate School of Medicine13
已完成
不适用
Preliminary study on the protective effects of habitual intake of BLP on the colorectal tumorsColorectal tumor (adenoma, adenocarcinoma)JPRN-UMIN000025389Graduate School of Medical Science, Kyoto Prefectural University of Medicine30